Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

New cytokine-targeted therapies show promise for treating alopecia areata.

Minoxidil and finasteride treat hair loss; more research needed for other options.

PRP more effective than minoxidil 5% for treating alopecia areata.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Personalized treatment plans are important for people with alopecia areata.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.